Cite

HARVARD Citation

    Vasan, N. et al. (n.d.). 1ODouble PIK3CA mutations in cis enhance PI3Kα oncogene activation and sensitivity to PI3Kα inhibitors in breast cancer. Annals of oncology. p. . [Online]. 
  
Back to record